Keyphrases
Positron Emission Tomography
100%
Clinical Impact
100%
Camera-based
100%
Recurrent Colorectal Cancer
100%
Fluorodeoxyglucose
100%
Clinical Value
50%
Treatment Strategy
33%
Oncologists
33%
Disease Stage
33%
Tomography System
33%
Surgeons
33%
Disease Treatment
16%
Medical Records
16%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
16%
Computed Tomography
16%
Cancer Cases
16%
Tumor Site
16%
Decision Analysis
16%
Tumor Tissue
16%
Conventional Imaging
16%
Metastatic Colorectal Cancer (mCRC)
16%
Staged Approach
16%
Recurrent or Metastatic
16%
Clinical Recurrence
16%
Positron Emission Tomography Study
16%
Downstaging
16%
Viable Tumor
16%
Coincidence Imaging
16%
Imaging Workup
16%
F-18 Fluorodeoxyglucose
16%
Medicine and Dentistry
Colorectal Cancer
100%
Positron Emission Tomography
100%
Fluorodeoxyglucose
100%
Disease
33%
Neoplasm
33%
Surgeon
33%
Oncologist
33%
Decision Making
16%
Recurrent Disease
16%
Computer Assisted Tomography
16%
Metastatic Colorectal Cancer
16%
Conventional Imaging
16%
Fluorodeoxyglucose F 18
16%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Cancer
100%
Fluorodeoxyglucose
100%
Disease
33%
Neoplasm
33%
Recurrent Disease
16%
Metastatic Colorectal Cancer
16%
Fluorodeoxyglucose F 18
16%